Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Cryoelectron Microscopy Reveals the Ultrastructure of Retroviral Integrase-DNA Complexes

By LabMedica International staff writers
Posted on 29 Feb 2016
Advanced imaging technology has revealed the ultrastructure of the retrovirus intasome, the protein complex that controls the insertion of viral DNA into the host target cell.

The integrase enzyme catalyses the integration of viral DNA into host target DNA, which is an essential step in the life cycle of all retroviruses. More...
Previous structural characterization of integrase-viral DNA complexes, or intasomes, from the nonpathogenic prototype foamy virus (PFV) revealed a functional integrase tetramer, and it is generally believed that intasomes derived from other retroviral genera use tetrameric integrase. However, the intasomes of orthoretroviruses, which include all known pathogenic species, have not been characterized structurally.

Investigators at the Salk Institute for Biological Studies (La Jolla, CA, USA) and Harvard Medical School (Boston, MA, USA) employed the advanced imaging technique cryoelectron microscopy (cryo-EM) to perform structural analysis studies on the pathogenic betaretrovirus, mouse mammary tumor virus (MMTV).

Researchers have historically relied on NMR and X-ray diffraction techniques to determine the structures of molecular complexes and proteins that play a role in the causes of various disease states. Structural information about a variety of medically important proteins and drugs has been obtained by these methods. Cryo-EM is a complementary analytical technique that provides near-atomic resolution without requirements for crystallization or limits on molecular size and complexity imposed by the other techniques. Cryo-EM allows the observation of specimens that have not been stained or fixed in any way, showing them in their native environment while integrating multiple images to form a three-dimensional model of the sample.

Results published in the February 17, 2016, online edition of the journal Nature revealed unexpected octameric integrase architecture for the MMTV. The structure was composed of two core integrase dimers, which interacted with the viral DNA ends and structurally mimicked the PFV integrase tetramer, and two flanking integrase dimers that engaged the core structure via their integrase carboxy-terminal domains. Contrary to the belief that tetrameric integrase components were sufficient to catalyze DNA insertion, the flanking integrase dimers were necessary for MMTV integrase activity.

"The details of how retroviruses integrate differ far more than previously thought and lead to entirely distinct patterns of infection," said contributing author Dr. Dmitry Lyumkis, a research fellow at the Salk Institute for Biological Studies.

"The MMTV intasome structure defines an unexpected novel paradigm for the structural basis of retroviral DNA integration," said senior author Dr. Alan Engelman, professor of medicine at Harvard Medical School.

Related Links:

Salk Institute for Biological Studies
Harvard Medical School



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Pipette Calibration System
Artel PCS®
New
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.